Endogenous opioids modulate hepatocyte apoptosis in a rat model of chronic cholestasis: The role of oxidative stress

Liver International

Volumn 27, Issue 4, 2007, Pages 538-547

  Payabvash, Seyedmehdi ^a   Kiumehr, Saman ^a   Nezami, Behtash Ghazi ^a   Zandieh, Ali ^a   Anvari, Pasha ^a   Tavangar, Seyed Mohammad ^b   Dehpour, Ahmad Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antioxidant enzyme; Apoptosis; Cholestasis; Glutathione; Liver injury; Naltrexone; Opioid receptors

Indexed keywords

ANTIOXIDANT; ENDORPHIN; ENZYME; GLUTATHIONE; NALTREXONE; OPIATE ANTAGONIST; OXIDIZING AGENT; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BILE DUCT LIGATION; CHOLESTASIS; CHRONIC DISEASE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; LIPID PEROXIDATION; LIVER CELL; LIVER INJURY; LIVER PROTECTION; LONG TERM CARE; MALE; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; RAT;

ANALGESICS, OPIOID; ANIMALS; APOPTOSIS; BIOLOGICAL FACTORS; CHOLESTASIS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HEPATOCYTES; LIVER; NALTREXONE; NARCOTIC ANTAGONISTS; OXIDATIVE STRESS; RATS;

EID: 34047192771     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2007.01457.x     Document Type: Article

References (57)

1. Guicciardi ME, Gores GJ. Bile acid-mediated hepatocyte apoptosis and cholestatic liver disease. Dig Liver Dis 2002; 34: 387-92.
2. Starzl TE, Demetris AJ, Van Thiel D. Liver transplantation (1). N Engl J Med 1989; 321: 1014-22.
3. Whitington PF, Balistreri WF. Liver transplantation in pediatrics: indications, contraindications, and pretransplant management. J Pediatr 1991; 118: 169-77.
4. Rust C, Gores GJ. Apoptosis and liver disease. Am J Med 2000; 108: 567-74.
5. Patel T, Gores GJ. Apoptosis and hepatobiliary disease. Hepatology 1995; 21: 1725-41.
6. Czaja MJ. Induction and regulation of hepatocyte apoptosis by oxidative stress. Antioxid Redox Signal 2002; 4: 759-67.
7. Ljubuncic P, Tanne Z, Bomzon A. Evidence of a systemic phenomenon for oxidative stress in cholestatic liver disease. Gut 2000; 47: 710-6.
8. Baron V, Muriel P. Role of glutathione, lipid peroxidation and antioxidants on acute bile-duct obstruction in the rat. Biochim Biophys Acta 1999; 1472: 173-80.
9. Bomzon A, Holt S, Moore K. Bile acids, oxidative stress, and renal function in biliary obstruction. Semin Nephrol 1997; 17: 549-62.
10. Tsai LY, Lee KT, Tsai SM, Lee SC, Yu HS. Changes of lipid peroxide levels in blood and liver tissue of patients with obstructive jaundice. Clin Chim Acta 1993; 215: 41-50.
11. Mani AR, Rasool R, Montagnese S, Dehpour AR. Endogenous opioids and liver disease. Scand J Gastroenterol 2006; 41: 1-11.
12. Bergasa NV, Vergalla J, Swain MG, Jones EA. Hepatic concentrations of proenkephalin-derived opioids are increased in a rat model of cholestasis. Liver 1996; 16: 298-302.
13. Swain MG. Alterations in hypothalamic mu-opiate receptor-mediated responses but not methionine enkephalin or proenkephalin messenger RNA levels in rats with acute cholestasis. Hepatology 1994; 20: 700-5.
14. Swain MG, MacArthur L, Vergalla J, Jones EA. Adrenal secretion of BAM-22P, a potent opioid peptide, is enhanced in rats with acute cholestasis. Am J Physiol 1994; 266: G201-5.
15. Swain MG, Rothman RB, Xu H, Vergalla J, Bergasa NV, Jones EA. Endogenous opioids accumulate in plasma in a rat model of acute cholestasis. Gastroenterology 1992; 103: 630-5.
16. Bergasa NV, Rothman RB, Vergalla J, Xu H, Swain MG, Jones EA. Central mu-opioid receptors are down-regulated in a rat model of cholestasis. J Hepatol 1992; 15: 220-4.
17. Jones EA, Neuberger J, Bergasa NV. Opiate antagonist therapy for the pruritus of cholestasis: The avoidance of opioid withdrawal-like reactions. QJM 2002; 95: 547-52.
18. Bergasa NV, Liau S, Homel P, Ghali V. Hepatic Met-enkephalin immunoreactivity is enhanced in primary biliary cirrhosis. Liver 2002; 22: 107-13.
19. Spivey JR, Jorgensen RA, Gores GJ, Lindor KD. Methionine-enkephalin concentrations correlate with stage of disease but not pruritus in patients with primary biliary cirrhosis. Am J Gastroenterol 1994; 89: 2028-32.
20. Sobocanec S, Balog T, Sverko V, Marotti T. Met-enkephalin modulation of age-related changes in red cell antioxidant status. Physiol Res 2005; 54: 97-104.
21. Sobocanec S, Kusic B, Sverko V, Balog T, Marotti T. Methionine-enkephalin modulated regulation of oxidant/antioxidant status in liver of CBA mice. Biogerontology 2006; 7: 53-62.
22. Yang CS, Tsai PJ, Chou ST, Niu YL, Lai JS, Kuo JS. The roles of reactive oxygen species and endogenous opioid peptides in ischemia-induced arrhythmia of isolated rat hearts. Free Radic Biol Med 1995; 18: 593-8.
23. Tegeder I, Geisslinger G. Opioids as modulators of cell death and survival - unraveling mechanisms and revealing new indications. Pharmacol Rev 2004; 56: 351-69.
24. Bhat RS, Bhaskaran M, Mongia A, Hitosugi N, Singhal PC. Morphine-induced macrophage apoptosis: Oxidative stress and strategies for modulation. J Leukoc Biol 2004; 75: 1131-8.
25. Marotti T, Sverko V, Hrsak I. Modulation of superoxide anion release from human polymorphonuclear cells by Met-and Leu-enkephalin. Brain Behav Immun 1990; 4: 13-22.
26. Zhang YT, Zheng QS, Pan J, Zheng RL. Oxidative damage of biomolecules in mouse liver induced by morphine and protected by antioxidants. Basic Clin Pharmacol Toxicol 2004; 95: 53-58.
27. Patel J, Manjappa N, Bhat R, Mehrotra P, Bhaskaran M, Singhal PC. Role of oxidative stress and heme oxygenase activity in morphine-induced glomerular epithelial cell growth. Am J Physiol Renal Physiol 2003; 285: F861-9.
28. Jaume M, Jacquet S, Cavailles P, et al. Opioid receptor blockade reduces Fas-induced hepatitis in mice. Hepatology 2004; 40: 1136-43.
29. Payabvash S, Beheshtian A, Salmasi AH, et al. Chronic morphine treatment induces oxidant and apoptotic damage in the mice liver. Life Sci 2006; 79: 972-80.
30. Gaskari SA, Mani AR, Ejtemaei-Mehr S, et al. Do endogenous opioids contribute to the bradycardia of rats with obstructive cholestasis? Fundam Clin Pharmacol 2002; 16: 273-9.
31. Ebrahimkhani MR, Kiani S, Oakley F, et al. Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated rats. Gut 2006; 55: 1606-16.
32. Paroni R, De Vecchi E, Cighetti G, et al. HPLC with o-phthalaldehyde precolumn derivatization to measure total, oxidized, and protein-bound glutathione in blood, plasma, and tissue. Clin Chem 1995; 41: 448-54.
33. Payabvash S, Ghahremani MH, Goliaei A, et al. Nitric oxide modulates glutathione synthesis during endotoxemia. Free Radic Biol Med 2006; 41: 1817-28.
34. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-8.
35. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med 1967; 70: 158-69.
36. Paoletti F, Mocali A. Determination of superoxide dismutase activity by purely chemical system based on NAD(P)H oxidation. Methods Enzymol 1990; 186: 209-20.
37. Aebi H. Catalase in vitro. Methods Enzymol 1984; 105: 121-6.
38. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-75.
39. Bird MA, Black D, Lange PA, Samson CM, Hayden M, Behrns KE. NFkappaB inhibition decreases hepatocyte proliferation but does not alter apoptosis in obstructive jaundice. J Surg Res 2003; 114: 110-7.
40. Miyoshi H, Rust C, Guicciardi ME, Gores GJ. NF-kB is activated in cholestasis and functions to reduce liver injury. Am J Pathol 2001; 158: 967-75.
41. Canbay A, Friedman S, Gores GJ. Apoptosis: The nexus of liver injury and fibrosis. Hepatology 2004; 39: 273-8.
42. Kountouras J, Billing BH, Scheuer PJ. Prolonged bile duct obstruction: A new experimental model for cirrhosis in the rat. Br J Exp Pathol 1984; 65: 305-11.
43. Jones BA, Gores GJ. Physiology and pathophysiology of apoptosis in epithelial cells of the liver, pancreas, and intestine. Am J Physiol 1997; 273: G1174-88.
44. Sokol RJ, Straka MS, Dahl R, et al. Role of oxidant stress in the permeability transition induced in rat hepatic mitochondria by hydrophobic bile acids. Pediatr Res 2001; 49: 519-31.
45. Yerushalmi B, Dahl R, Devereaux MW, Gumpricht E, Sokol RJ. Bile acid-induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition. Hepatology 2001; 33: 616-26.
46. Bergasa NV, Sabol SL, Young WS, Kleiner DE, Jones EA. Cholestasis is associated with preproenkephalin mRNA expression in the adult rat liver. Am J Physiol 1995; 268: G346-54.
47. Ling W, Wesson DR. Drugs of abuse - opiates. West J Med 1990; 152: 565-72.
48. Kannan K, Jain SK. Oxidative stress and apoptosis. Pathophysiology 2000; 7: 153-63.
49. Meister A, Anderson ME. Glutathione. Annu Rev Biochem 1983; 52: 711-60.
50. Roberts SM, Skoulis NP, James RC. A centrally-mediated effect of morphine to diminish hepatocellular glutathione. Biochem Pharmacol 1987; 36:3001-5.
51. Skoulis NP, James RC, Harbison RD, Roberts SM. Depression of hepatic glutathione by opioid analgesic drugs in mice. Toxicol Appl Pharmacol 1989; 99: 139-47.
52. Gujral JS, Farhood A, Bajt ML, Jaeschke H. Neutrophils aggravate acute liver injury during obstructive cholestasis in bile duct-ligated mice. Hepatology 2003; 38: 355-63.
53. Simpkins CO, Ives N, Tate E, Johnson M. Naloxone inhibits superoxide release from human neutrophils. Life Sci 1985; 37: 1381-6.
54. Lin SL, Lee YM, Chang HY, Cheng YW, Yen MH. Effects of naltrexone on lipopolysaccharide-induced sepsis in rats. J Biomed Sci 2005; 12: 431-40.
55. Neuschwander-Tetri BA, Nicholson C, Wells LD, Tracy TF. Cholestatic liver injury down-regulates hepatic glutathione synthesis. J Surg Res 1996; 63: 447-51.
56. Orellana M, Rodrigo R, Thielemann L, Guajardo V. Bile duct ligation and oxidative stress in the rat: Effects in liver and kidney. Comp Biochem Physiol C Toxicol Pharmacol 2000; 126: 105-11.
57. Purucker E, Winograd R, Roeb E, Matern S. Glutathione status in liver and plasma during development of biliary cirrhosis after bile duct ligation. Res Exp Med 1998; 198: 167-74.